Nifty

:

17274.30

Sensex

:

58065.47

386.95 (2.29%)
1276.66 (2.25%)

Login

Nifty
Sensex

:
:

17274.30
58065.47

386.95 (2.29%)
1276.66 (2.25%)

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

71/99

BSE: 507789 | NSE: JAGSNPHARM

Watchlist

NSE BSE

354.80

03-Oct-2022

Day's Open
Day's High
Day's Low
Previous Close

356.55
363.80
351.50
358.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

22292
79.70
418.90
123.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

925.97
70.64
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

899.81
1.13%
7.50

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.11
12.31
12.55

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.89
-
24.78

PAT CAGR (%)

10 Years
5 Years
3 Years

26.75
-
35.53

P:E (Median)

8 Years
5 Years
3 Years

18.71
13.04
17.46

P:BV (Average)

8 Years
5 Years
3 Years

3.23
3.23
3.23

EV:EBITDA (Average)

8 Years
5 Years
3 Years

275.42
245.83
12.07

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 60.60 54.05 12.12% 52.14 42.84 21.71% 54.47 57.10 -4.61% 59.49 56.35 5.57%
Expenses 54.18 44.78 20.99% 51.51 37.72 36.56% 48.86 50.62 -3.48% 49.21 51.52 -4.48%
EBITDA 6.42 9.27 -30.74% 0.63 5.12 -87.70% 5.61 6.48 -13.43% 10.28 4.83 112.84%
EBIDTM 10.59% 17.16% 1.20% 11.94% 10.30% 11.35% 17.28% 8.58%
Other Income 0.31 0.82 -62.20% 0.28 2.66 -89.47% 1.95 0.53 267.92% 0.29 0.41 -29.27%
Interest 0.01 0.11 -90.91% 0.06 0.13 -53.85% 0.06 0.14 -57.14% 0.06 0.12 -50.00%
Depreciation 0.19 0.28 -32.14% 0.65 0.26 150.00% 0.37 0.27 37.04% 0.23 0.28 -17.86%
PBT 0.72 9.71 -92.58% 0.20 7.38 -97.29% 7.14 6.61 8.02% 10.28 4.85 111.96%
Tax 0.35 2.86 -87.76% 0.18 2.28 -92.11% 1.73 1.18 46.61% 2.97 0.85 249.41%
PAT 0.37 6.85 -94.60% 0.02 5.10 -99.61% 5.41 5.43 -0.37% 7.31 4.01 82.29%
PATM 0.61% 12.67% 0.05% 11.90% 9.93% 9.51% 12.28% 7.11%
EPS 0.14 2.61 -94.64% 0.01 1.95 -99.49% 2.06 2.07 -0.48% 2.79 1.53 82.35%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 226.70 226.10 187.95 158.57 166.83 126.53 143.87 143.49 138.15 143.85 166.46 Net Sales Growth 7.78% 20.30% 18.53% -4.95% 31.85% -12.05% 0.26% 3.87% -3.96% -13.58% Cost Of Goods Sold 94.74 95.78 80.78 56.19 72.85 61.11 58.95 59.13 68.68 64.71 86.16 Gross Profit 131.96 130.31 107.17 102.38 93.98 65.42 84.92 84.36 69.47 79.14 80.30 GP Margin 58.21% 57.63% 57.02% 64.56% 56.33% 51.70% 59.03% 58.79% 50.29% 55.02% 48.24% Total Expenditure 203.76 200.30 168.87 150.04 157.49 137.64 138.10 131.68 129.42 133.17 156.41 Power & Fuel Cost - 0.47 0.52 0.76 1.41 1.00 2.12 2.26 1.77 2.23 2.55 % Of Sales - 0.21% 0.28% 0.48% 0.85% 0.79% 1.47% 1.58% 1.28% 1.55% 1.53% Employee Cost - 57.68 53.98 50.37 46.61 41.88 40.95 37.84 32.11 37.83 37.25 % Of Sales - 25.51% 28.72% 31.77% 27.94% 33.10% 28.46% 26.37% 23.24% 26.30% 22.38% Manufacturing Exp. - 1.05 0.62 0.51 0.73 0.96 1.34 1.70 1.01 1.57 2.01 % Of Sales - 0.46% 0.33% 0.32% 0.44% 0.76% 0.93% 1.18% 0.73% 1.09% 1.21% General & Admin Exp. - 28.56 18.75 23.55 19.03 16.31 16.44 13.61 9.64 8.55 8.87 % Of Sales - 12.63% 9.98% 14.85% 11.41% 12.89% 11.43% 9.48% 6.98% 5.94% 5.33% Selling & Distn. Exp. - 15.32 12.99 17.45 13.20 11.25 13.74 12.96 11.53 14.36 15.45 % Of Sales - 6.78% 6.91% 11.00% 7.91% 8.89% 9.55% 9.03% 8.35% 9.98% 9.28% Miscellaneous Exp. - 1.45 1.22 1.20 3.66 5.14 4.56 4.19 4.67 3.92 15.45 % Of Sales - 0.64% 0.65% 0.76% 2.19% 4.06% 3.17% 2.92% 3.38% 2.73% 2.47% EBITDA 22.94 25.80 19.08 8.53 9.34 -11.11 5.77 11.81 8.73 10.68 10.05 EBITDA Margin 10.12% 11.41% 10.15% 5.38% 5.60% -8.78% 4.01% 8.23% 6.32% 7.42% 6.04% Other Income 2.83 3.34 4.39 2.53 1.43 0.46 0.47 0.66 0.11 0.06 0.32 Interest 0.19 0.29 0.51 0.51 0.75 0.66 2.64 5.30 4.46 5.38 5.13 Depreciation 1.44 1.53 1.09 1.13 1.02 0.32 1.99 3.09 2.71 2.83 2.71 PBT 18.34 27.32 21.87 9.41 9.00 -11.63 1.60 4.08 1.67 2.53 2.54 Tax 5.23 7.73 4.81 1.54 1.79 -0.08 2.53 0.82 0.50 0.41 0.70 Tax Rate 28.52% 28.29% 21.99% 16.37% 19.89% 0.69% 17.57% 20.10% 29.94% 16.21% 27.56% PAT 13.11 19.59 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 PAT before Minority Interest 13.11 19.59 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.78% 8.66% 9.08% 4.96% 4.33% -9.13% 8.24% 2.26% 0.85% 1.47% 1.10% PAT Growth -38.71% 14.83% 116.77% 9.00% - - 264.92% 177.78% -44.81% 15.85% EPS 5.00 7.48 6.51 3.00 2.76 -4.41 4.53 1.24 0.45 0.81 0.70

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 130.86 121.93 111.03 104.47 98.05 109.91 98.36 95.43 98.59 98.37 Share Capital 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 117.76 108.83 97.93 91.37 84.95 96.81 85.27 82.33 85.49 85.27 Non-Current Liabilities 3.44 1.88 3.09 3.12 3.19 3.26 3.61 3.60 4.08 4.50 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 Long Term Provisions 1.26 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 34.16 40.40 34.57 28.19 28.58 29.44 57.31 55.19 53.58 50.13 Trade Payables 16.29 18.05 11.71 11.86 9.09 8.98 9.73 7.87 5.08 6.51 Other Current Liabilities 9.42 10.89 8.16 5.60 6.10 7.12 6.61 6.24 5.48 3.99 Short Term Borrowings 0.00 6.79 6.40 3.79 8.30 7.93 38.49 39.31 35.96 33.09 Short Term Provisions 8.45 4.67 8.30 6.95 5.09 5.41 2.48 1.77 7.06 6.55 Total Liabilities 168.46 164.21 148.69 135.78 129.82 142.61 159.28 154.22 156.25 153.00 Net Block 24.75 25.72 24.44 21.64 21.32 21.59 51.61 51.96 56.41 58.35 Gross Block 60.28 60.12 58.17 55.00 53.66 52.88 90.35 87.61 87.01 85.75 Accumulated Depreciation 35.53 34.40 33.74 33.36 32.34 31.28 38.74 35.65 30.60 27.41 Non Current Assets 57.68 43.73 52.39 38.23 35.20 32.50 58.32 58.43 64.94 66.46 Capital Work in Progress 0.00 0.00 1.90 3.95 3.04 0.00 0.00 0.00 2.35 2.33 Non Current Investment 20.58 12.06 11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 9.93 5.66 14.53 12.63 10.84 10.90 6.71 6.47 6.19 5.78 Other Non Current Assets 2.42 0.29 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 110.78 120.48 96.31 97.56 94.61 110.11 100.96 95.79 91.31 86.54 Current Investments 22.14 3.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 29.74 29.72 29.32 32.69 51.43 47.62 39.84 33.06 30.59 30.07 Sundry Debtors 15.58 12.66 21.45 20.75 25.15 39.41 41.69 44.89 45.22 42.20 Cash & Bank 26.15 60.23 40.49 38.53 14.51 20.06 15.53 15.02 12.60 10.34 Other Current Assets 17.16 0.27 0.52 0.94 3.51 3.03 3.90 2.83 2.90 3.93 Short Term Loans & Adv. 13.55 14.34 4.52 4.64 3.27 2.80 3.90 2.83 2.90 3.93 Net Current Assets 76.62 80.08 61.74 69.37 66.03 80.68 43.65 40.60 37.73 36.41 Total Assets 168.46 164.21 148.70 135.79 129.81 142.61 159.28 154.22 156.25 153.00

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 5.60 28.22 11.89 30.90 -1.58 -3.24 9.04 4.30 7.52 12.05 PBT 27.32 21.87 9.41 9.00 -11.63 14.40 4.08 1.67 2.53 2.54 Adjustment 2.91 -2.09 -0.57 0.33 1.26 -8.63 7.73 7.05 8.15 7.52 Changes in Working Capital -17.13 11.59 4.84 19.71 8.79 -6.13 -1.96 -4.09 -2.65 2.50 Cash after chg. in Working capital 13.10 31.37 13.69 29.05 -1.58 -0.36 9.85 4.63 8.02 12.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.50 -3.15 -1.80 1.85 0.00 -2.88 -0.82 -0.33 -0.51 -0.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -26.21 -2.26 -11.07 -0.83 -3.37 41.29 -2.09 -0.46 -1.21 -3.39 Net Fixed Assets -0.16 -0.05 -1.12 -2.25 -3.82 37.47 -2.74 1.75 -1.28 -3.71 Net Investments -27.41 -3.92 -11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 1.36 1.71 1.44 1.42 0.45 3.82 0.65 -2.21 0.07 0.32 Cash from Financing Activity -12.30 -6.83 -1.82 -6.05 -0.60 -33.52 -6.43 -1.42 -4.04 -8.19 Net Cash Inflow / Outflow -32.91 19.13 -1.01 24.02 -5.55 4.53 0.52 2.41 2.26 0.46 Opening Cash & Equivalents 58.94 39.81 40.82 14.51 20.06 15.53 15.02 12.60 10.34 9.88 Closing Cash & Equivalent 26.03 58.94 39.81 38.53 14.51 20.06 15.53 15.02 12.60 10.34

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 46.96 43.55 39.39 36.89 34.43 38.96 34.55 33.43 32.86 32.63 ROA 11.78% 10.90% 5.53% 5.43% -8.48% 7.86% 2.08% 0.75% 1.37% 1.19% ROE 16.52% 15.70% 7.88% 7.72% -12.01% 12.32% 3.65% 1.35% 2.47% 2.15% ROCE 22.64% 19.43% 9.46% 9.80% -10.52% 14.26% 7.32% 4.93% 6.57% 6.42% Fixed Asset Turnover 3.76 3.18 2.80 3.07 2.38 2.03 1.62 1.59 1.68 2.01 Receivable days 22.80 33.13 48.57 50.22 93.07 102.03 109.58 118.23 109.72 90.52 Inventory Days 48.00 57.34 71.38 92.03 142.78 110.02 92.27 83.52 76.13 69.93 Payable days 65.42 67.24 34.46 31.91 27.07 22.17 21.36 15.26 9.95 12.35 Cash Conversion Cycle 5.37 23.23 85.49 110.33 208.78 189.88 180.49 186.49 175.90 148.10 Total Debt/Equity 0.00 0.06 0.06 0.04 0.09 0.08 0.43 0.45 0.42 0.39 Interest Cover 96.82 43.59 19.31 13.08 -16.69 6.44 1.77 1.37 1.47 1.49

Top Investors:

vanaja sundar iyer

mukul mahavir agrawal

investor education and protection fund authority ministry of corporate affairs

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharma - Quarterly Results
9th Aug 2022, 19:35 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback